B6.Cg-Tg(Col13a1)2Pih/Oulu

Status

Available to order

EMMA IDEM:09885
Citation informationRRID:IMSR_EM:09885 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Tg(Col13a1)2Pih/Oulu
Alternative nameB6.Cg-Tg(Col13a1)2Pih/Oulu
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Col13a1)2Pih
Gene/Transgene symbolTg(Col13a1)2Pih

Information from provider

ProviderTaina Pihlajaniemi
Provider affiliationFaculty of Biochemistry and Molecular medicine, University of Oulu
Genetic informationThe construct is 4,7 kb in length. It consists of the following fragments. First fragment is a 2,5 kb starting from -984 (with respect to the ATG codon) and thus containing the Col13a1 promoter, and the first protein coding exon as well as 0,8 kb of following sequences in the first intron. This is linked to the second genomic fragment containing 159 bp in 3' of the first intron and 91 bp of the second exon. This is further linked to a Col13a1 cDNA clone containing rest of the second exon and exons 3-41. Finally, sequences coding for a hemagglutinin (HA) tag, transcription termination and SV40 polyA are linked 3' from the cDNA clone.
Phenotypic informationHomozygous:
Transgenic female mice are not used for breeding due to the high bone mass phenotype and concomitant problems in delivery.

Heterozygous:
High bone mass apparent from 3-4 weeks onwards in transgenics. Most noticeable in proximal long bones but also calvarial bones are affected.
Breeding historyThe construct was microinjected into one-cell stage embryos from B6D2F1 (hybrid of C57BL/6J x DBA/2J). The line was maintained as hybrid for about a decade, after which it was frozen using C57BL/6JOlaHsd females. The line was recovered and maintained thereafter using C57BL/6JOlaHsd females.
References
  • Type XIII collagen strongly affects bone formation in transgenic mice.;Ylönen Riikka, Kyrönlahti Tuomo, Sund Malin, Ilves Mika, Lehenkari Petri, Tuukkanen Juha, Pihlajaniemi Taina, ;2005;Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research;20;1381-93; 16007336
  • Integrin α11β1 is a receptor for collagen XIII.;Koivunen Jarkko, Tu Hongmin, Kemppainen Antti, Anbazhagan Padmanabhan, Finnilä Mikko A, Saarakkala Simo, Käpylä Jarmo, Lu Ning, Heikkinen Anne, Juffer André H, Heino Jyrki, Gullberg Donald, Pihlajaniemi Taina, ;2021;Cell and tissue research;383;1135-1153; 33306155
  • Collagen XIII-derived ectodomain regulates bone angiogenesis and intracortical remodeling.;Koivunen Jarkko, Kemppainen Antti V, Finnilä Mikko A, Keski-Filppula Riikka, Härönen Heli, Tu Hongmin, Pellikka Henri, Heikkinen Anne, Kylmäoja Elina, Sormunen Raija, Miinalainen Ilkka, Saarakkala Simo, Izzi Valerio, Pihlajaniemi Taina, ;2019;Matrix biology : journal of the International Society for Matrix Biology;83;6-25; 31220558
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland

Literature references

  • Type XIII collagen strongly affects bone formation in transgenic mice.;Ylönen Riikka, Kyrönlahti Tuomo, Sund Malin, Ilves Mika, Lehenkari Petri, Tuukkanen Juha, Pihlajaniemi Taina, ;2005;Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research;20;1381-93; 16007336
  • Integrin α11β1 is a receptor for collagen XIII.;Koivunen Jarkko, Tu Hongmin, Kemppainen Antti, Anbazhagan Padmanabhan, Finnilä Mikko A, Saarakkala Simo, Käpylä Jarmo, Lu Ning, Heikkinen Anne, Juffer André H, Heino Jyrki, Gullberg Donald, Pihlajaniemi Taina, ;2021;Cell and tissue research;383;1135-1153; 33306155
  • Collagen XIII-derived ectodomain regulates bone angiogenesis and intracortical remodeling.;Koivunen Jarkko, Kemppainen Antti V, Finnilä Mikko A, Keski-Filppula Riikka, Härönen Heli, Tu Hongmin, Pellikka Henri, Heikkinen Anne, Kylmäoja Elina, Sormunen Raija, Miinalainen Ilkka, Saarakkala Simo, Izzi Valerio, Pihlajaniemi Taina, ;2019;Matrix biology : journal of the International Society for Matrix Biology;83;6-25; 31220558

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).